Posts Tagged ‘Germany’

Smart Mobility for India: Needs, Opportunities and Challenges

Friday, August 17th, 2012

India finds itself in a precarious situation. While the lack of efficient and effective mediums of mobility for public-at-large outside metropolitan cities continues to cause loss of productivity and stifle economic growth in a considerable manner; the economic growth in major urban centres and the resultant growth of passenger vehicles and two-wheelers is leading to heavy traffic jams and pollution, again causing loss of productivity and chocking of economic growth. This article argues that a viable solution to these entwined and complex challenges lies in implementing “smart mobility” solutions. This could prove to be the next growth driver and present immense opportunities for Indo-German collaboration, in both private and public sectors. []

This article, authored by Rajnish Tiwari, has been published in GermanyContact India (issue 02/2012, August). To continue reading click here. An extended, unedited version of the article with additional information/graphs can be accessed here (PDF, 524 KB).

India orders ‘compulsory license’ for Bayer’s cancer drug

Tuesday, March 13th, 2012

According to one report in the Economic Times (13.03.2012):

The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany’s Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry’s anxiety over the use of the controversial compulsory licensing provision.

The outgoing patent controller of India, PH Kurian, on Monday granted the country’s first compulsory licence to Hyderabad-based Natco Pharma, permitting it to manufacture and market a generic version of Nexavar, a medicine used for treating liver and kidney cancer, in India for just 3% of the patented drug’s price in return for paying 6% royalty on sales to Bayer.

[…] Bayer is expected to legally challenge the decision. “We will evaluate our options to further defend our intellectual property rights in India,” a company spokesman said. […]

Source: “Natco Pharma bags licence to sell Bayer’s cancer drug Nexavar” (Economic Times, 13.03.2012)

Also see: “India patent ruling may open door for cheaper HIV drugs” (Economic Times, 13.03.2012)

Research & Innovation: “China presents a challenge for Germany”

Monday, March 12th, 2012

Expert Commission calls for stronger cooperation, but remains mindful of risks

China’s enormous potential for innovation is perhaps the major challenge for Germany’s research sector. Now a global player, CHina has been growing strong in areas of special importance for German companies: knowledge-intensive industries and services. This is among the conclusions reached by the Expert Commission on Research and Innovation (EFI) in its 2012 annual report, which was presented to Chancellor Merkel on Wednesday. While the Commission sees opportunities in intensified cooperation with China, it advises against overly generous transfer of scientifc findings, especially in application-relevant areas.

The complete press release can be downloaded here.

Source: Press release by Expert Commission on Research and Innovation (EFI), dated: 29.02.2012.

Indo-German Trade Continues its Dream Run in 2011

Friday, March 9th, 2012

Indo-German trade registered a staggering growth of 18.7% in 2011. The bilateral trade volume in calendar year 2011 is estimated to have stood at €18.4 billion, up from €15.5 billion in 2010. The growth in bilateral exports and imports outperformed the overall growth in Germany’s trade with the rest of the world. While Germany’s exports to India grew by 17.1% on yearly basis and stood at €10.87 billion, the imports grew by 20.2% reaching €7.5 billion.

Read the complete report titled “Indo-German Trade Continues its Dream Run in 2011: Bilateral business defies financial crisis and economic slowdown“.

Frugal Innovations for the ‘Unserved’ Customer: An Assessment of India’s Attractiveness as a Lead Market for Cost-effective Products

Thursday, March 1st, 2012

New publication from the Institute for Technology and Innovation Management, Hamburg University of Technology (TUHH)

Title: Frugal Innovations for the ‘Unserved’ Customer: An Assessment of India’s Attractiveness as a Lead Market for Cost-effective Products
Authored by: Rajnish Tiwari and Cornelius Herstatt
Publication date: March 2012


This study builds on our previous work, which had questioned the validity of certain assumptions of the lead market theory in the face of changing ground realities in a globalized world. Sustained economic growth and proven technological capabilities in some “emerging economies” like China and India call for a reassessment of the appropriateness of the “conventional wisdom” that had held true until recently. While our previous study had “re-built” a theoretical background of the lead market model by introducing some new elements, and doing away with certain others, with the help of two in-depth case studies; the purpose of the present study is to specifically assess India’s potential as a lead market for cost-effective frugal innovations.

The study crystallizes the inherent characteristics of frugal innovations, their development process and market success in the domestic and overseas markets by analyzing four successful product innovations from selected industries in India. The factors identified thus are then incorporated in the theoretic model to derive propositions about India’s lead market potential. Whereas affordability and economies of scale have traditionally constituted the primary concern for frugal innovations, an increasing shift towards “value proposition” is identified. Intensifying competition and growing customer aspirations are changing the nature of frugal innovations. The hitherto unserved customer demands attractive designs and modern technologies to come out of his shell of “non-consumption”. Our research confirms that frugal innovations can benefit end-consumers and firms, simultaneously. Better-designed products also have positive impact on the lead market potential, creating a virtuous cycle. The study also discovered that the increasing need for sophistication coupled with continued cost pressures is shifting the product development processes into the domain of “open global innovation”, which also helps reduce the negative country-of-origin effects faced by developing countries. The research would have implications for location decisions in setting up global innovation/R&D activities.

Keywords: Lead Markets; Frugal Innovations; India; Bottom of the Pyramid; Global Innovation; Open Innovation; Emerging Economies.